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tions of Alaska, and for reversed elucidation of potential genetic 
resistance markers indicating metacestode abortion [4]. 
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Nitric Oxide in Cerebral Malaria 
Colleagues-Cerebral malaria is an important complication of 
Plasriiodizrrii falciparwii infection and a major cause of infant 
mortality in Africa. The pathophysiology of cerebral malaria 
remains incompletely understood. Recently, a link between cy- 
tokines, nitric oxide (NO), and cerebral malaria was proposed 
[ 1. 21. It was hypothesized that intravascular NO, induced by 
tumor necrosis factor in endothelial cells and vascular smooth 
muscle, diffuses through the blood-brain barrier and interferes 
with neurologic function. Furthermore, NO is thought to in- 
crease intracranial pressure. a common feature in cerebral ma- 
laria in African children [3], through increased vasodilatation. 
Our data do not support this concept. 
We studied the evolution of NO plasma concentrations in 28 
African children (mean age & SD, 4.4 f 3 years) with cerebral 
malaria in Yaoundé. All children presented with unrousable 
coma and P. falciparum parasitemia. Coma depth was assessed 
according to the modified Glasgow coma scale for young chil- 
dren [4]. Other causes of coma were excluded. After treatment 
with quinine (25 mg of base/kg daily for 8 days), the clinical 
outcome was favorable in 2 1 cases; 4 children developed neuro- 
logic sequelae. Three children died: after 12 h, 3 days, and 4 
days. Mean duration of coma for the 25 surviving children was 
45.1 2 3 1.4 h. NO plasma concentrations were measured on the 
day ofadmission (day 1) and on days 2,3, 5, and 8 (discharge). 
Stable NO end products (NO; and NO;) were measured by 
means of an automated procedure, as described previously [5]. 
On day 1, mean NO concentration in 28 children was 44.3 f 
Reprints or correspondence: Dr. Pascal Ringwald, ORSTOM/OCEAC, 
BP288, Yaounde, Cameroon. 
The Journal of Infectious Diseases 
O 1994 by The University of Chicago. All rights reserved. 
1994;169:1417-8 ‘rd 
0022-1 899/94/6906-005OSO I .O0 
5 .  Liance M, Vuitton D, Guerret-Stocker S .  Carbillet JP. Grimaud JA, 
Houin R. Experimental alveolar echinococcosis. Suitability of a mu- 
rine model of intrahepatic infection by Ecliinococcirs niultilocularis 
for immunological studies. Experientia 1984;40: 1436-9. 
6. Kroeze WK, Tanner CE. Ec/iinococcirs riitrlíilocirlaris: susceptibility and 
responses to infection in inbred mice. Int J Parasitol 1987;17:873- 
83. 
7. Gottstein B. Mesarina B, Tanner I, et al. Specific cellular and humoral 
immune responses in patients with different long-term courses of 
alveolar echinococcosis (infection with Echinococcus riiulíiloctrlaris). 
Am J Trop Med Hyg 1991;45:734-42. 
8. Tiercy JM. Jeannet M, Mach B. A new approach for the analysis of 
HLA class 11 polymorphism: HLA oligotyping. Blood Rev 19904:9- 
15. 
9. Bettens F. Pichler WJ, de Weck AL. Incorporation of biotinylated nu- 
cleotides for the quantification of PCR-amplified HIV-I DNA by 
chemiluminescence. Eur J Chem Clin Biochem 1991;29:685-8. 
IO. Doherty DG. Vaughan RW, Donaldson PT, Mowatt AP. HLA DQA, 
DQB and DRB genotyping by oligonucleotide analysis: distribution 
of alleles and haplotypes in British Caucasoids. Hum Immunol 
19923453-63, 
36.5 pM. Children with favorable outcome presented with a 
higher mean NO concentration (49.9 f 40.3 pM) than those 
with neurologic sequelae (30.6 4 15.5 pM) or those who died 
(23.7 k 4.6 p M ) .  NO concentrations were higher in children 
with a coma score of 3 (11 = 1 I ;  63.2 k 49 pM) than in children 
with a coma score of 1 or 2 (ti = 17; 32.2 f 18.6 p M ) .  These 
differences were not statistically significant. NO concentrations 
were negatively correlated with the duration of coma (Spearman 
rank test, r’ = -.49, P < .02), indicating that the duration of 
coma was significantly longer in children with NO plasma levels 
~ 4 4 . 3  p M  than in those with NO plasma levels superior to the 
mean (53.6 f 27.5 vs. 32.4 f 34.0 h: P c .02). No significant 
correlation between NO level and platelet or white blood cell 
counts, blood glucose level, parasitemia, hemoglobin level, or 
body temperature was found. 
We observed an increase of mean NO concentration after 24 
h of quinine treatment in children with favorable outcome 
(group A); in children with sequelae (group B), this was found 
after 48 h. By day 3, mean NO level was higher in group A (44.2 
k 50.9 pM) than in group B ( 12.8 k 3.9 pM) (Mann-Whitney U 
test, P = .03). Similar results were observed at day 5 (62.1 f 
68.1 vs. 16.2 f 7.1 pM, P < .04; figure I). 
Although NO plasma concentrations are higher during cere- 
bral malaria than during uncomplicated malaria attacks (unpub- 
lished data), our results seem to refute the hypothesis that in- 
creased NO levels are detrimental in the development of 
cerebral malaria. In a murine model, N-monomethyl-L-arginine, 
an inhibitor ofNO synthase, prevented neither the development 
of neurologic symptoms nor the death of Plasriiodiuriz berghei- 
infected mice [6, 71. Furthermore, treatment with a competitive 
NO synthase inhibitor had a deleterious effect in complicated 
murine Plasrnodiurii viiickei malaria [SI. Therefore, it has been 
suggested that NO has a protective role in cerebral malaria [9]. 
Further investigations are being done to confirm the protective 
effect of NO in human pathology as suggested by murine models 
and by our preliminary results. 
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Figure 1. NO plasma concentrations in children with favorable ~iutcome 
(group .A.ii = 2 I )and children with neurologic bequelae (group B. n = 4). D 
= day. 
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Patients with Plasmodium falciparum Malaria and 
Plasmodium vivax Malaria Show Increased Nitrite and 
Nitrate Plasma Levels 
Colleagues-The most severe complication of PlasiiiodiwiiJizI- 
cipartini malaria is the cerebral syndrome. which accounts for 
> I  million deaths every year. It has been proposed that nitric 
oxide accounts. at least in part, for the pathophysiology seen in 
human cerebral malaria [ I ] .  Nitric oxide, a ubiyuitouslj occur- 
ring molecule, is released from several cells in response to cyto- 
kines, including tumor necrosis factor-a [?l. which is associated 
with cerebral malaria [3]. Several in Vico studies in humans 
show that nitric oxide forms during sepsis or immunotherapy 
['J. However, it is unclear whether nitric oxide is produced in 
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humans during malaria and whether increased nitric oxide for- 
mation is associated h i t h  the patholog! seen in malaria. 
We stqdied the nitric oside plasma Iriels in patients infected 
with P. f i k i p ~ r t i i i i  or Plasiiioditiiii i1iw.y in Vietnam and Brazil. 
The Vietnam study included 34 patients with cerebral malaria 
(mean age 35 years. range 15-67) hospitalized in the Cho Ray 
Hospital of Ho Chi h4inh Citj. I ?  patients with uncomplicated 
malaria, and 4 controls. Nitric oxide plasma levels were deter- 
mined on the day of admission by an automated procedure as 
described [4]. The median nitric oxide levels nere as follows: 
controls. 23 p M  (range. 15-31): patients with uncomplicated 
malaria, 40 pJ1 (range. 12-93): and patients with cerebral symp- 
toms. 71 ,ul\/ (ranze. 16-38;). which were significantly higher 
than levels in the other two groups (Kruskall Wallis test. P < 
.O I ). Eight patients with cerebral malaria died. Their nitric oxide 
levels (median 75. range 31-487) did not differ from those of 
sur\ ivors. 
The Brazil study. done in an outpatient clinic in Rio Branco, 
Acre. included 15 health) controls and 34 patients (age range. 
16-50 years: mean. 26) with uncomplicated P. j d - i p m x i n  ma- 
laria. Twenty-eight patients were nonimmune, and 16 were clas- 
sified JS semiimmune [SI. A third group consisted o f 6  I patients 
(age range. 15-60 years: mean, 28) with P. \Yrmu malaria. Nitric 
oxide Ie\els determined on admission were as follous: healthy 
